| Literature DB >> 30154882 |
Michał Aporowicz1, Paweł Domosławski1, Piotr Czopnik1, Krzysztof Sutkowski1, Krzysztof Kaliszewski1.
Abstract
INTRODUCTION: The perioperative complication rate of adrenalectomy varies between 1.7% and 30.7% in the medical literature. This study presents outcomes of adrenalectomy in our center and tries to point out risk factors for perioperative problems.Entities:
Keywords: adrenal gland neoplasms; adrenalectomy; complications; laparoscopy; teaching
Year: 2018 PMID: 30154882 PMCID: PMC6111348 DOI: 10.5114/aoms.2018.77257
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Demographic, surgical and pathologic profile of patients and procedures
| Year | Number of procedures | Side of procedure | Value | ||
|---|---|---|---|---|---|
| 2004 | 6 | Unilateral: | 171 (96.6%) | ||
| 2005 | 5 | Right | 79 (46.2%) | ||
| 2006 | 7 | Left | 92 (53.8%) | ||
| 2007 | 8 | Simultaneous bilateral | 6 (3.4%) | ||
| 2008 | 19 | Total | 177 | ||
| 2009 | 18 | ||||
| 2010 | 15 | Adrenocortical adenoma (ACA) | 85 (48.0%) | Benign: 156 (88.1%) | |
| 2011 | 13 | Nodular hyperplasia (NH) | 22 (12.4%) | ||
| 2012 | 14 | ACA/NH (distinction impossible) | 3 (1.7%) | ||
| 2013 | 31 | Pheochromocytoma | 19 (10.7%) | ||
| 2014 | 22 | No pathology | 7 (4.0%) | ||
| 2015 (until June) | 19 | Myelolipoma | 7 (4.0%) | ||
| Total | 177 | Hematoma | 4 (2.3%) | ||
| Cyst | 6 (3.4%) | ||||
| Females | 126 (71.2) | Hemangioma | 2 (1.1%) | ||
| Males | 51 (28.8) | Ganglioneuroma | 1 (0.6%) | ||
| Metastases | 12 (6.8%) | Malignant: 17 (9.6%) | |||
| 18–19 | 0 (0.0%) | Adrenocortical carcinoma (ACC) | 3 (1.7%) | ||
| 20–29 | 4 (2.3%) | Lymphoma (diffuse large B cell l) | 1 (0.6%) | ||
| 30–39 | 11 (6.2%) | Schwannoma | 1 (0.6%) | ||
| 40–49 | 28 (15.8%) | No material obtained | 4 (2.3%) | ||
| 50–59 | 67 (37.9%) | Total | 177 | ||
| 60–69 | 53 (29.9%) | ||||
| 70–79 | 13 (7.3%) | Tumor, non-functioning | 99 (55.9%) | ||
| 80+ | 1 (0.6%) | Cyst, non-functioning | 3 (1.7%) | ||
| Mean | 55.9 ±10.9 | Pheochromocytoma or suspicion | 24 (13.6%) | ||
| Cushing syndrome | 18 (10.2%) | ||||
| Retroperitoneal, open | 2 (1.1%) | Conn syndrome | 19 (10.7%) | ||
| Laparotomy | 52 (29.4%) | Cushing and Conn syndrome | 1 (0.6%) | ||
| Laparoscopy | 105 (59.3%) | Metastases or suspicion | 12 (6.8%) | ||
| Laparoscopy with conversion | 9 (5.1%) | Recurrent tumor | 1 (0.6%) | ||
| Retroperitoneoscopic | 9 (5.1%) | Total | 177 | ||
| Total | 177 |
Scheduled resection was aborted due to extensive adhesions or associated bleeding.
Description of each complication: patient’s data, type (bleeding, lesion, others), severity (in Clavien-Dindo classification) and management
| Sex | Age | Side | Comorbidities | Previous surgery or simultaneous procedure | Indication | Approach | Complication | Type | Severity | Management | Histopath. report |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 65 | R | Arterial hypertension | – | Tumor | O | Abscess of surgical site and right pleural effusion | S/other | III b | 3 relaparotomies: lavage, drainage adhesions release, right pleural drainage | Myelolipoma |
| F | 73 | L | – | – | Tumor | L → conv | Iatrogenic perforation of the left (splenic) flexure of the colon | S/lesion | Conversion to laparotomy, 2-layer suture of colon wall | ACA | |
| M | 64 | R | – | – | L | Surgical site hematoma | S/bleed | III b | Readmission → laparotomy, evacuation of hematoma and subhepatic drainage | ACA | |
| F | 35 | L | – | Simultaneous: tumor removed with the distal part of pancreas | Tumor | L | Surgical site hematoma and hemorrhagic infarction of the spleen due to splenic vein thrombosis | S/lesion | III b | Readmitted about 10 days later because of abdominal pain → US → laparotomy, evacuation of hematoma and splenectomy; see | ACA, normal pancreas; partial splenic necrosis |
| F | 54 | L | Rectal cancer | Simultaneous: LAR, bil adnexectomy, appendectomy, splenectomy | Tumor | O | Localized peritonitis due to sigmo-rectal fistula | S/other | IV a | Relaparotomy (new sigmo-rectal anastomosis) → transfer to ICU → readmission → discharged | Adrenal hyperplasia, rectal ca |
| F | 68 | L | Acromegaly | Previous: removal of brainstem tumor 14 y before, partial gastrectomy and thyroidectomy 1 y before | Tumor | L | 4-mm diaphragm perforation during removing adhesions after gastrectomy; small left pneumothorax | S/lesion | Laparoscopic Z-shaped suture without conversion to laparotomy; pneumothorax did not require chest tube | ACA | |
| F | 43 | R | – | – | Cushing syndrome | R | Subcutaneous emphysema of the torso due to high insufflation pressure | S/other | I | Emphysema gradually disappeared over days on its own | ACA |
| F | 55 | L | – | – | Tumor | L | Bleeding, hemoperitoneum | S/bleed | III b | Laparotomy, source of bleeding was torn capsule of the spleen → splenectomy | ACA |
| F | 55 | R | Type 2 diabetes | Previous: left nephrectomy and adrenalectomy due to renal cancer | Tumor (meta susp.) | L | Paresis of left upper extremity ← temporary dysfunction of brachial plexus ← position on the left side during surgery | S/other | I d | Rehabilitation, physiotherapy | ACA |
| F | 52 | R | – | Previous: LAR 6 y before | Tumor | O | Surgical wound hematoma | S/other | I | Drainage at bedside | ACA |
| F | 53 | R | – | – | Cushing syndrome | L → conv | Tear of right adrenal vein, massive hemorrhage from IVC | S/bleed | Rapid conversion to laparotomy, ligation of bleeding vein, hemostasis | ACA | |
| M | 52 | L | – | Simultaneous, not planned: splenectomy and left nephrectomy | Tumor (malignancy susp.) | L → conv | Removal of left adrenal gland with spleen and left kidney due to infiltration | S/lesion | IV b | Respiratory and circulatory insufficiency → ICU → readmission → discharged; ↑ creatinine → ambulatory counseling | Adrenal cyst, hem-angioma?; no malignancy |
| F | 54 | R + L | MEN 2 syndrome | Previous: thyroidectomy due to medullar thyroid cancer (MTC) | Pheo-chromo-cytoma (bilateral) | O | Left-side pneumonia | M | II | Antibiotics | Pheochro-mocytoma |
| F | 58 | L | – | Simultaneous: tumor removed with tail of pancreas | Tumor | O | Anemia despite no signs of bleeding from surgical site | M | II | Transfusion of 2 packed red blood cells | Clear-cell ACA |
| F | 55 | L | – | – | Tumor | O | Thrombophlebitis: superficial in left lower extremity and deep in left upper one | M | II | Subcutaneous injections of particulate heparin | Large (7 × 5 cm) ACA |
| F | 73 | L | – | Previous: LHC 2 y before due to colon cancer | Tumor (meta susp.) | O | Pneumonia | M | II | Antibiotics | ACA |
| M | 56 | L | Arterial hypertension, paroxysmal tachycardia | – | Tumor (pheo susp.) | O | Postoperative tachycardia up to 120 bpm, hyperthermia up to 38.4°C | M | II | Antibiotic (ampicillin) and β-blocker (propranolol) | ACA 2.5 cm |
| M | 38 | R | Pancreatic head tumor | Simultaneous: Whipple pancreatoduodenectomy | Tumor | O | Epidural catheter → hematoma of spinal canal → compression of spinal cord → paraplegia | M | V | Laminectomy and cord decomp-ression – unsuccessful; permanent paraplegia, vast decubitus ulcers, chronic renal failure, various septic complications; death 4 years later due to brain abscess | Adrenal nodular hyperplasia; chronic pancreatitis |
It is an adenoma composed of neoplastic clear cells containing intracytoplasmic lipid droplets [20].
The analysis of possible risk factors for complications
| Variable | All patients (1) | All complications (2) | Surgical complications (3) | Medical complications (4) | Statistical significance |
|---|---|---|---|---|---|
| Sex: | |||||
| Female | 126 (71.2%) | 13 (10.3%) | 9 (7.1%) | 4 (3.2%) | |
| Male | 51 (28.8%) | 5 (9.8%) | 3 (5.9%) | 2 (3.9%) | |
| Indication: | |||||
| Tumor or cyst | 102 (57.6%) | 13 (12.7%) | 9 (8.8%) | 4 (3.9%) | |
| Hyperactivity | 62 (35.0%) | 4 (6.5%) | 2 (3.2%) | 2 (3.2%) | |
| Metastases/recidivation | 13 (7.4%) | 1 (7.7%) | 1 (7.7%) | 0 | |
| Uni-/bilateral: | |||||
| Unilateral | 171 (96.6%) | 17 (9.9%) | 12 (7.0%) | 5 (2.8%) | |
| Bilateral | 6 (3.4%) | 1 (16.7%) | 0 | 1 (16.7%) | |
| Laterality (for unilateral): | |||||
| Right | 79 (46.2%) | 7 (8.9%) | 6 (7.6%) | 1 (1.3%) | |
| Left | 92 (53.8%) | 10 (10.9%) | 6 (6.5%) | 4 (4.3%) | |
| Method: | |||||
| Laparotomy or conversion | 61 (34.5%) | 12 (19.7%) | 6 (9.8%) | 6 (9.8%) | |
| Retroperitoneal, open | 2 (1.1%) | 0 | 0 | 0 | |
| Laparoscopic | 105 (59.3%) | 5 (4.8%) | 5 (4.8%) | 0 | |
| Retroperitoneoscopic | 9 (5.1%) | 1 (11.1%) | 1 (11.1%) | 0 | |
| Scope: | |||||
| Only adrenalectomy | 164 (92.7%) | 15 (9.1%) | 11 (6.7%) | 4 (2.4%) | |
| Additional procedures | 13 (7.3%) | 3 (23.0%) | 1 (7.7%) | 2 (15.4%) | |
| Operator: | |||||
| No. 1 | 75 (42.4%) | 5 (6.7%) | 4 (5.3%) | 1 (1.3%) | |
| No. 2 | 35 (19.8%) | 5 (14.3%) | 5 (14.3%) | 0 | |
| No. 3 | 11 (6.2%) | 2 (18.2%) | 1 (9.1%) | 1 (9.1%) | |
| No. 4 (resident) | 10 (5.6%) | 0 | 0 | 0 | |
| No. 5 | 10 (5.6%) | 1 (10.0%) | 1 (10.0%) | 0 | |
| No. 6 | 8 (4.5%) | 0 | 0 | 0 | |
| No. 7 | 5 (2.8%) | 2 (40.0%) | 1 (20.0%) | 1 (20.0%) | Resident vs. |
| No. 8 | 5 (2.8%) | 1 (20.0%) | 0 | 1 (20.0%) | |
| No. 9 | 4 (2.3%) | 0 | 0 | 0 | |
| No. 10 | 3 (1.7%) | 0 | 0 | 0 | |
| No. 11 | 3 (1.7%) | 0 | 0 | 0 | |
| No. 12 | 2 (1.1%) | 1 (50.0%) | 0 | 1 (50.0%) | |
| No. 13 | 2 (1.1%) | 1 (50.0%) | 0 | 1 (50.0%) | |
| No. 14 | 2 (1.1%) | 0 | 0 | 0 | |
| No. 15 | 1 (0.6%) | 0 | 0 | 0 | |
| No. 16 | 1 (0.6%) | 0 | 0 | 0 | |
| Laterality: | Bleeding | Lesion | Others | ||
| Right | 79 (46.2%) | 2 (2.5%) | 0 (0.0%) | 4 (5.1%) | |
| Left | 92 (53.8%) | 1 (1.1%) | 4 (4.3%) | 1 (1.1%) |